Toxic epidermal necrolysis successfully treated with infliximab

J Investig Allergol Clin Immunol. 2013;23(1):61-3.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / therapeutic use*
  • Female
  • Humans
  • Immunologic Factors / administration & dosage
  • Immunologic Factors / therapeutic use*
  • Infliximab
  • Male
  • Middle Aged
  • Stevens-Johnson Syndrome / drug therapy*
  • Treatment Outcome
  • Young Adult

Substances

  • Antibodies, Monoclonal
  • Immunologic Factors
  • Infliximab